BridgeBio Pharma's total assets for Q3 2024 were $664.98M, a decrease of -16.29% from the previous quarter. BBIO total liabilities were $1.88B for the fiscal quarter, a 0.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.